GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.40
Bid: 29.20
Ask: 29.90
Change: -0.35 (-1.18%)
Spread: 0.70 (2.397%)
Open: 29.50
High: 30.00
Low: 29.40
Prev. Close: 29.75
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EKF Diagnostics Says Annual Performance To Be Ahead Of Expectations

Mon, 09th Nov 2020 11:57

(Alliance News) - EKF Diagnostics Holdings PLC on Monday forecast full-year earnings ahead of expectations and also ahead of the year prior.

The healthcare products manufacturer said as a result of its strong performance in October combined with expected orders for the rest of the year, it expects to deliver 2020 revenue of GBP60 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP23 million.

For comparison, for 2019, EKF Diagnostics posted revenue of GBP44.9 million and adjusted ebitda of GBP12.0 million.

The company attributes its positive performance and confident outlook 2020 to "significantly-improved" trading in its core business in the final quarter, along with continued orders for the PrimeStore MTM Covid-19 sample collection device.

Shares in EKF Diagnostics were trading 0.1% lower at 77.45 pence each on Monday in London.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Jan 2015 12:05

UK WINNERS & LOSERS: Gowin Rockets On Funding Agreement

Read more
28 Jan 2015 08:27

EKF Diagnostics Expects Full Year Results At Higher End Of Guidance

Read more
23 Jan 2015 08:23

UK MORNING BRIEFING: Shares Up, Pound Below USD1.50 After ECB Move

Read more
23 Jan 2015 07:52

EKF Diagnostic And ANGLE Combine Technologies For Cancer Study

Read more
17 Dec 2014 09:12

EKF Diagnostics warns on profit on currency hit and lower revenue from buys

Medical group EKF Diagnostics warned on annual profits after taking a currency hit and saying revenue from newly acquired companies was likely to be lower than expected. EKF said acquisitions during the year of Diaspect, Selah Genomics and STI were set to contribute at least £6.1m to overall revenue

Read more
1 Oct 2014 10:46

DIRECTOR DEALINGS: EKF Diagnostics Chairman Buys 100,000 Shares

Read more
30 Sep 2014 09:50

Tuesday broker round-up UPDATE

Aberdeen: Goldman Sachs ups target price from 540p to 560pp retaining a buy recommendation. African Barrick Gold: Deutsche Bank moves target price from 270p to 280p and reiterates a hold recommendation. Investec lowers target price from 260p to 258p, while upgrading to buy. African Minerals: Invest

Read more
23 Sep 2014 07:18

EKF Diagnostics Signs Research Deal With Massachusetts General Hospital

Read more
15 Sep 2014 11:10

UK WINNERS & LOSERS: Micro Focus Jumps 14% On Reverse Takeover Deal

Read more
15 Sep 2014 08:55

EKF On Track To Meet Full-Year Expectations Despite Swing To Loss

Read more
23 Jul 2014 09:04

EKF Confident In Meeting Market Expectations On First-Half Progress

Read more
23 Jul 2014 07:34

UK MORNING BRIEFING: Renishaw And Capita Lead London Shares Higher

Read more
8 Jul 2014 09:12

EKF Signs Distribution Contract; Partner Wins Regulatory Approval

Read more
2 Jun 2014 09:41

EKF Takes "Major Step" Towards Detecting Cancer In Blood; Appoints CTO

LONDON (Alliance News) - EKF Diagnostics Holdings PLC Monday said it has taken a major step towards detecting cancer cells in blood samples, and has appointed a new technology boss. Separately, EKF said it has appointed Tito Bacarese-Hamilton as its new Chief Technology Officer. Bacarese-Ha

Read more
2 Jun 2014 08:38

EKF Diagnostics takes big step in cancer detection

Medical group EKF Diagnostics says a partnership in which it is involved has made a major step towards detecting cancer in blood. EKF said first results from its collaboration with German group Gilupi had successfully shown detection of gene mutations from as few as three or less isolated cells and

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.